Actively Recruiting
Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care in Urban and Rural Areas of Sweden
Led by Joint Academy · Updated on 2024-09-27
50000
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
Sponsors
J
Joint Academy
Lead Sponsor
L
Lund University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating how digital and face-to-face delivery of first-line osteoarthritis (OA) treatment compare in reaching patients across Sweden. The study aims to improve access to care for people with hip or knee OA by understanding if a digital program can increase equal access in both urban and rural areas. This observational study compares a traditional face-to-face program called Better management of patients with OsteoArthritis (BOA) to a newer digital version called Joint Academy (JA). The digital program JA offers daily video instructions, individualized exercises, and educational information via a mobile app. Participants communicate with a physical therapist through chat and phone for supervision throughout the program. The face-to-face BOA program provides treatment at primary care clinics and has been in use since 2008. Data on patient participation from both programs during 2021-2023 will be collected and compared, including geographic factors like population density and county size. Participants' postal codes and primary care center locations will be recorded to analyze treatment utilization per 100,000 residents in different regions. The study collects data from the BOA registry and JA database to assess how well each program reaches patients. The goal is to determine if digital delivery improves access and adherence compared to face-to-face care. The study runs until July 2025 and involves adults diagnosed with hip or knee OA who have consented to participate.
CONDITIONS
Brief Title
Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients in the Joint Academy database who participated in the treatment program for osteoarthritis and gave informed consent for research
- Radiographic or clinical diagnosis of hip or knee osteoarthritis by a physical therapist or physician
- Individuals without prior diagnosis confirmed by an orthopedic surgeon or physiotherapist via telephone, following NICE criteria and Swedish National Guidelines
- From October 1st, 2021, patients must have undergone a physical examination by a doctor or physiotherapist before entering treatment
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for physical examination by a doctor or physiotherapist before entering treatment
Duration - Duration of treatment varies based on individual program participation
Participants receive first-line osteoarthritis treatment either digitally through the Joint Academy app or face-to-face at a primary care clinic.
Participants engage with treatment through daily app exercises and asynchronous communication or face-to-face visits as per program schedule
Duration - Up to 3 years
Participants' utilization and adherence to osteoarthritis treatment are monitored over time to assess access and effectiveness.
Data collected from program registries without additional participant visits
Trial Site Locations
Total: 1 location
1
Joint Academy
Malmö, Sweden
Actively Recruiting
Research Team
L
Leif E Dahlberg, Senior professor
H
Håkan Nero, Med dr
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here